HIF-1α-activated long non-coding RNA KDM4A-AS1 promotes hepatocellular carcinoma progression via the miR-411-5p/KPNA2/AKT pathway
alpha Karyopherins
0301 basic medicine
Jumonji Domain-Containing Histone Demethylases
Carcinoma, Hepatocellular
QH573-671
Liver Neoplasms
Hypoxia-Inducible Factor 1, alpha Subunit
Article
3. Good health
Gene Expression Regulation, Neoplastic
MicroRNAs
03 medical and health sciences
Cell Movement
Cell Line, Tumor
Disease Progression
Humans
RNA, Long Noncoding
Cytology
Hypoxia
Proto-Oncogene Proteins c-akt
Cell Proliferation
DOI:
10.1038/s41419-021-04449-2
Publication Date:
2021-12-13T10:06:57Z
AUTHORS (11)
ABSTRACT
Abstract Hepatocellular carcinoma (HCC) is the most common type of liver cancer with poor clinical outcomes. Long non-coding RNAs (lncRNAs) are extensively involved in tumorigenesis and progression HCC. However, more investigations should be carried out on novel lncRNAs their effects Here we identified a lncRNA KDM4A-AS1, which was aberrantly overexpressed HCC tissues, associated unfavorable features prognosis patients. KDM4A-AS1 promoted cell proliferation, migration, invasion vitro contributed to growth lung metastasis vivo. Mechanistically, inversely modulated by miR-411-5p at post-transcriptional level facilitated Karyopherin α2 (KPNA2) expression competitively binding miR-411-5p, thereby activating AKT pathway. KPNA2 silencing, overexpression, inhibitor (MK2206) consistently reversed KDM4A-AS1-enhanced mobility, EMT cells. as hypoxia-responsive gene transactivated hypoxia-inducible factor 1α (HIF-1α) In turn, regulated HIF-1α through KPNA2/AKT signaling Hence, this study revealed lncRNA, via KDM4A-AS1/KPNA2/HIF-1α loop. Our findings provide promising prognostic therapeutic target for
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (41)
CITATIONS (48)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....